Starting in 2024, UW School of Medicine will cease contributing data for U.S. News & World Report medical school rankings.
BBVA Foundation honors UW Medicine’s David Baker and British scientists Demis Hassabis and John Jumper for artificial intelligence in protein design.
Study reveals new therapeutic target to subdue autoimmune inflammation caused by loss of regulatory T cell function.
The $20 million in philanthropic support makes this the largest, publicly announced medical school deanship in the country.
Treatment of childhood-onset hearing loss can be more precisely tailored with information on specific genetic cause.
A small pilot, the first such test in humans, will examine whether higher-caloric meals create inflammation in the hypothalamus.
A variety of resources and enjoyable activities are offered for people with memory loss, their caregivers and families.
In a novel lab environment using mini kidney structures, drugs blocked the swelling of tubes seen with polycystic kidney disease.
Harnessing light energy to rejuvenate mitochondrial membrane potential slowed aging in C. elegans.
Most Alzheimer’s drugs in development target beta-amyloid, but targeting another protein, called tau, may be needed.